Cargando…
NMR-based metabolomics in real-time monitoring of treatment induced toxicity and cachexia in head and neck cancer: a method for early detection of high risk patients
INTRODUCTION: Nutritional treatment in head and neck squamous cell carcinoma cancer (HNSCC) patients undergoing radio-/chemo-radiotherapy (RT/CHRT) is complex and requires a multidisciplinary approach. In this study the real-time dynamic changes in serum metabolome during RT/CHRT in HNSCC patients w...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6697714/ https://www.ncbi.nlm.nih.gov/pubmed/31420744 http://dx.doi.org/10.1007/s11306-019-1576-4 |
_version_ | 1783444419129638912 |
---|---|
author | Boguszewicz, Ł. Bieleń, A. Mrochem-Kwarciak, J. Skorupa, A. Ciszek, M. Heyda, A. Wygoda, A. Kotylak, A. Składowski, K. Sokół, M. |
author_facet | Boguszewicz, Ł. Bieleń, A. Mrochem-Kwarciak, J. Skorupa, A. Ciszek, M. Heyda, A. Wygoda, A. Kotylak, A. Składowski, K. Sokół, M. |
author_sort | Boguszewicz, Ł. |
collection | PubMed |
description | INTRODUCTION: Nutritional treatment in head and neck squamous cell carcinoma cancer (HNSCC) patients undergoing radio-/chemo-radiotherapy (RT/CHRT) is complex and requires a multidisciplinary approach. In this study the real-time dynamic changes in serum metabolome during RT/CHRT in HNSCC patients were monitored using NMR-based metabolomics. OBJECTIVES: The main goal was to find the metabolic markers that could help prevent of acute radiation sequelae (ARS) escalation. METHODS: 170 HNSCC patients were treated radically with RT/CHRT. Blood samples were collected weekly, starting from the day before the treatment and stopping within the week after the RT/CHRT completion, resulting in a total number of 1328 samples. (1)H NMR spectra were acquired on Bruker 400 MHz spectrometer at 310 K and analyzed using principal component analysis (PCA) and orthogonal partial least squares discriminant analysis (OPLS-DA). Additional statistical analyses were performed on the quantified metabolites. RESULTS: PCA has detected a group of distinct outliers corresponding to ketone bodies (3HB, Ace, AceAce). These outliers were found to identify the individuals at high risk of weight loss, mainly by the 3HB changes, which was confirmed by the patients’ medical data. In the OPLS-DA models a transition from the lowest to the highest weight loss is seen, defining the metabolic time trajectories for the patients from the studied groups during RT/CHRT. 3HB is a relatively sensitive marker that allows earlier identification of the patients at higher risk of > 10% weight loss. CONCLUSION: Our findings indicate that metabolic alterations, characteristic for malnutrition or cachexia, can be detected already at the beginning of the treatment, making it possible to monitor the patients with a higher risk of weight loss. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s11306-019-1576-4) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-6697714 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Springer US |
record_format | MEDLINE/PubMed |
spelling | pubmed-66977142019-09-06 NMR-based metabolomics in real-time monitoring of treatment induced toxicity and cachexia in head and neck cancer: a method for early detection of high risk patients Boguszewicz, Ł. Bieleń, A. Mrochem-Kwarciak, J. Skorupa, A. Ciszek, M. Heyda, A. Wygoda, A. Kotylak, A. Składowski, K. Sokół, M. Metabolomics Original Article INTRODUCTION: Nutritional treatment in head and neck squamous cell carcinoma cancer (HNSCC) patients undergoing radio-/chemo-radiotherapy (RT/CHRT) is complex and requires a multidisciplinary approach. In this study the real-time dynamic changes in serum metabolome during RT/CHRT in HNSCC patients were monitored using NMR-based metabolomics. OBJECTIVES: The main goal was to find the metabolic markers that could help prevent of acute radiation sequelae (ARS) escalation. METHODS: 170 HNSCC patients were treated radically with RT/CHRT. Blood samples were collected weekly, starting from the day before the treatment and stopping within the week after the RT/CHRT completion, resulting in a total number of 1328 samples. (1)H NMR spectra were acquired on Bruker 400 MHz spectrometer at 310 K and analyzed using principal component analysis (PCA) and orthogonal partial least squares discriminant analysis (OPLS-DA). Additional statistical analyses were performed on the quantified metabolites. RESULTS: PCA has detected a group of distinct outliers corresponding to ketone bodies (3HB, Ace, AceAce). These outliers were found to identify the individuals at high risk of weight loss, mainly by the 3HB changes, which was confirmed by the patients’ medical data. In the OPLS-DA models a transition from the lowest to the highest weight loss is seen, defining the metabolic time trajectories for the patients from the studied groups during RT/CHRT. 3HB is a relatively sensitive marker that allows earlier identification of the patients at higher risk of > 10% weight loss. CONCLUSION: Our findings indicate that metabolic alterations, characteristic for malnutrition or cachexia, can be detected already at the beginning of the treatment, making it possible to monitor the patients with a higher risk of weight loss. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s11306-019-1576-4) contains supplementary material, which is available to authorized users. Springer US 2019-08-16 2019 /pmc/articles/PMC6697714/ /pubmed/31420744 http://dx.doi.org/10.1007/s11306-019-1576-4 Text en © The Author(s) 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
spellingShingle | Original Article Boguszewicz, Ł. Bieleń, A. Mrochem-Kwarciak, J. Skorupa, A. Ciszek, M. Heyda, A. Wygoda, A. Kotylak, A. Składowski, K. Sokół, M. NMR-based metabolomics in real-time monitoring of treatment induced toxicity and cachexia in head and neck cancer: a method for early detection of high risk patients |
title | NMR-based metabolomics in real-time monitoring of treatment induced toxicity and cachexia in head and neck cancer: a method for early detection of high risk patients |
title_full | NMR-based metabolomics in real-time monitoring of treatment induced toxicity and cachexia in head and neck cancer: a method for early detection of high risk patients |
title_fullStr | NMR-based metabolomics in real-time monitoring of treatment induced toxicity and cachexia in head and neck cancer: a method for early detection of high risk patients |
title_full_unstemmed | NMR-based metabolomics in real-time monitoring of treatment induced toxicity and cachexia in head and neck cancer: a method for early detection of high risk patients |
title_short | NMR-based metabolomics in real-time monitoring of treatment induced toxicity and cachexia in head and neck cancer: a method for early detection of high risk patients |
title_sort | nmr-based metabolomics in real-time monitoring of treatment induced toxicity and cachexia in head and neck cancer: a method for early detection of high risk patients |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6697714/ https://www.ncbi.nlm.nih.gov/pubmed/31420744 http://dx.doi.org/10.1007/s11306-019-1576-4 |
work_keys_str_mv | AT boguszewiczł nmrbasedmetabolomicsinrealtimemonitoringoftreatmentinducedtoxicityandcachexiainheadandneckcanceramethodforearlydetectionofhighriskpatients AT bielena nmrbasedmetabolomicsinrealtimemonitoringoftreatmentinducedtoxicityandcachexiainheadandneckcanceramethodforearlydetectionofhighriskpatients AT mrochemkwarciakj nmrbasedmetabolomicsinrealtimemonitoringoftreatmentinducedtoxicityandcachexiainheadandneckcanceramethodforearlydetectionofhighriskpatients AT skorupaa nmrbasedmetabolomicsinrealtimemonitoringoftreatmentinducedtoxicityandcachexiainheadandneckcanceramethodforearlydetectionofhighriskpatients AT ciszekm nmrbasedmetabolomicsinrealtimemonitoringoftreatmentinducedtoxicityandcachexiainheadandneckcanceramethodforearlydetectionofhighriskpatients AT heydaa nmrbasedmetabolomicsinrealtimemonitoringoftreatmentinducedtoxicityandcachexiainheadandneckcanceramethodforearlydetectionofhighriskpatients AT wygodaa nmrbasedmetabolomicsinrealtimemonitoringoftreatmentinducedtoxicityandcachexiainheadandneckcanceramethodforearlydetectionofhighriskpatients AT kotylaka nmrbasedmetabolomicsinrealtimemonitoringoftreatmentinducedtoxicityandcachexiainheadandneckcanceramethodforearlydetectionofhighriskpatients AT składowskik nmrbasedmetabolomicsinrealtimemonitoringoftreatmentinducedtoxicityandcachexiainheadandneckcanceramethodforearlydetectionofhighriskpatients AT sokołm nmrbasedmetabolomicsinrealtimemonitoringoftreatmentinducedtoxicityandcachexiainheadandneckcanceramethodforearlydetectionofhighriskpatients |